Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

CKD: A Call for an Age-Adapted Definition.

Delanaye P, Jager KJ, Bökenkamp A, Christensson A, Dubourg L, Eriksen BO, Gaillard F, Gambaro G, van der Giet M, Glassock RJ, Indridason OS, van Londen M, Mariat C, Melsom T, Moranne O, Nordin G, Palsson R, Pottel H, Rule AD, Schaeffner E, Taal MW, White C, Grubb A, van den Brand JAJG.

J Am Soc Nephrol. 2019 Sep 10. pii: ASN.2019030238. doi: 10.1681/ASN.2019030238. [Epub ahead of print] Review.

PMID:
31506289
2.

Peritoneal Ultrafiltration for Heart Failure: Lessons from a Randomized Controlled Trial.

Dukka H, Kalra PA, Wilkie M, Bhandari S, Davies SJ, Barratt J, Squire I, Odudu A, Selby NM, McIntyre C, Robertson F, Taal MW.

Perit Dial Int. 2019 Sep-Oct;39(5):486-489. doi: 10.3747/pdi.2018.00272.

PMID:
31501293
3.

Quantitative assessment of renal structural and functional changes in chronic kidney disease using multi-parametric magnetic resonance imaging.

Buchanan CE, Mahmoud H, Cox EF, McCulloch T, Prestwich BL, Taal MW, Selby NM, Francis ST.

Nephrol Dial Transplant. 2019 Jun 29. pii: gfz129. doi: 10.1093/ndt/gfz129. [Epub ahead of print]

PMID:
31257440
4.

Biological variation of measured and estimated glomerular filtration rate in patients with chronic kidney disease.

Rowe C, Sitch AJ, Barratt J, Brettell EA, Cockwell P, Dalton RN, Deeks JJ, Eaglestone G, Pellatt-Higgins T, Kalra PA, Khunti K, Loud FC, Morris FS, Ottridge RS, Stevens PE, Sharpe CC, Sutton AJ, Taal MW, Lamb EJ; eGFR-C Study Group.

Kidney Int. 2019 Aug;96(2):429-435. doi: 10.1016/j.kint.2019.02.021. Epub 2019 Mar 7.

PMID:
31084924
5.

Feasibility and effectiveness of pre-emptive rehabilitation in persons approaching dialysis (PREHAB).

Willingham FC, Speelman I, Hamilton J, von Fragstein G, Shaw S, Taal MW.

J Ren Care. 2019 Mar;45(1):9-19. doi: 10.1111/jorc.12262. Epub 2019 Jan 16.

PMID:
30648345
6.

Long-term outcomes after AKI-a major unmet clinical need.

Selby NM, Taal MW.

Kidney Int. 2019 Jan;95(1):21-23. doi: 10.1016/j.kint.2018.09.005.

PMID:
30606416
7.

The Association of Nutritional Factors and Skin Autofluorescence in Persons Receiving Hemodialysis.

Viramontes Hörner D, Selby NM, Taal MW.

J Ren Nutr. 2019 Mar;29(2):149-155. doi: 10.1053/j.jrn.2018.07.004. Epub 2018 Oct 8.

PMID:
30309781
8.

Magnetic resonance imaging biomarkers for chronic kidney disease: a position paper from the European Cooperation in Science and Technology Action PARENCHIMA.

Selby NM, Blankestijn PJ, Boor P, Combe C, Eckardt KU, Eikefjord E, Garcia-Fernandez N, Golay X, Gordon I, Grenier N, Hockings PD, Jensen JD, Joles JA, Kalra PA, Krämer BK, Mark PB, Mendichovszky IA, Nikolic O, Odudu A, Ong ACM, Ortiz A, Pruijm M, Remuzzi G, Rørvik J, de Seigneux S, Simms RJ, Slatinska J, Summers P, Taal MW, Thoeny HC, Vallée JP, Wolf M, Caroli A, Sourbron S.

Nephrol Dial Transplant. 2018 Sep 1;33(suppl_2):ii4-ii14. doi: 10.1093/ndt/gfy152.

9.

Personalized medicine in nephrology: a novel approach or just good medicine?

Taal MW.

Curr Opin Nephrol Hypertens. 2018 Nov;27(6):395-397. doi: 10.1097/MNH.0000000000000448. No abstract available.

PMID:
30095481
10.

What every doctor needs to know about chronic kidney disease.

Kazmi I, Gullapudi L, Taal MW.

Br J Hosp Med (Lond). 2018 Aug 2;79(8):438-443. doi: 10.12968/hmed.2018.79.8.438.

PMID:
30070954
11.

What is the value of multidisciplinary care for chronic kidney disease?

Fluck RJ, Taal MW.

PLoS Med. 2018 Mar 27;15(3):e1002533. doi: 10.1371/journal.pmed.1002533. eCollection 2018 Mar.

12.

The Association of Serum Free Light Chains With Mortality and Progression to End-Stage Renal Disease in Chronic Kidney Disease: Systematic Review and Individual Patient Data Meta-analysis.

Fraser SDS, Fenton A, Harris S, Shardlow A, Liabeuf S, Massy ZA, Burmeister A, Hutchison CA, Landray M, Emberson J, Kalra PA, Ritchie JP, Cockwell P, Taal MW.

Mayo Clin Proc. 2017 Nov;92(11):1671-1681. doi: 10.1016/j.mayocp.2017.08.021. Epub 2017 Nov 1. Review. Erratum in: Mayo Clin Proc. 2017 Dec;92 (12 ):1866. Kalra, Phil [corrected to Kalra, Phil A].

PMID:
29101935
13.

Effect of weekend admission on mortality associated with severe acute kidney injury in England: A propensity score matched, population-based study.

Kolhe NV, Fluck RJ, Taal MW.

PLoS One. 2017 Oct 10;12(10):e0186048. doi: 10.1371/journal.pone.0186048. eCollection 2017.

14.

The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study.

Shardlow A, McIntyre NJ, Fraser SDS, Roderick P, Raftery J, Fluck RJ, McIntyre CW, Taal MW.

PLoS Med. 2017 Oct 10;14(10):e1002400. doi: 10.1371/journal.pmed.1002400. eCollection 2017 Oct.

15.

Sodium MRI: a new frontier in imaging in nephrology.

Francis S, Buchanan CE, Prestwich B, Taal MW.

Curr Opin Nephrol Hypertens. 2017 Nov;26(6):435-441. doi: 10.1097/MNH.0000000000000370. Review.

PMID:
28877041
16.
17.

Patients' Experiences After CKD Diagnosis: A Meta-ethnographic Study and Systematic Review.

Teasdale EJ, Leydon G, Fraser S, Roderick P, Taal MW, Tonkin-Crine S.

Am J Kidney Dis. 2017 Nov;70(5):656-665. doi: 10.1053/j.ajkd.2017.05.019. Epub 2017 Jul 29. Review.

PMID:
28764920
18.

Formula to detect high sodium excretion from spot urine in chronic kidney disease patients.

Nerbass FB, Hallvass AE, Taal MW, Pecoits-Filho R.

J Bras Nefrol. 2017 Mar;39(1):23-28. doi: 10.5935/0101-2800.20170004. Portuguese, English.

19.

Intradialytic Cardiac Magnetic Resonance Imaging to Assess Cardiovascular Responses in a Short-Term Trial of Hemodiafiltration and Hemodialysis.

Buchanan C, Mohammed A, Cox E, Köhler K, Canaud B, Taal MW, Selby NM, Francis S, McIntyre CW.

J Am Soc Nephrol. 2017 Apr;28(4):1269-1277. doi: 10.1681/ASN.2016060686. Epub 2016 Nov 10.

20.

Chronic kidney disease: towards a risk-based approach.

Taal MW.

Clin Med (Lond). 2016 Dec;16(Suppl 6):s117-s120. Review.

21.

A simple care bundle for use in acute kidney injury: a propensity score-matched cohort study.

Kolhe NV, Reilly T, Leung J, Fluck RJ, Swinscoe KE, Selby NM, Taal MW.

Nephrol Dial Transplant. 2016 Nov;31(11):1846-1854. Epub 2016 May 4.

PMID:
27190331
22.

Regional Variation in Acute Kidney Injury Requiring Dialysis in the English National Health Service from 2000 to 2015 - A National Epidemiological Study.

Kolhe NV, Fluck RJ, Muirhead AW, Taal MW.

PLoS One. 2016 Oct 17;11(10):e0162856. doi: 10.1371/journal.pone.0162856. eCollection 2016.

23.

Multimorbidity in people with chronic kidney disease: implications for outcomes and treatment.

Fraser SD, Taal MW.

Curr Opin Nephrol Hypertens. 2016 Nov;25(6):465-472. Review.

PMID:
27490909
24.

Chronic Kidney Disease in Primary Care: Outcomes after Five Years in a Prospective Cohort Study.

Shardlow A, McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW.

PLoS Med. 2016 Sep 20;13(9):e1002128. doi: 10.1371/journal.pmed.1002128. eCollection 2016 Sep.

25.

International Criteria for Acute Kidney Injury: Advantages and Remaining Challenges.

Selby NM, Fluck RJ, Kolhe NV, Taal MW.

PLoS Med. 2016 Sep 13;13(9):e1002122. doi: 10.1371/journal.pmed.1002122. eCollection 2016 Sep.

26.

Where now for proteinuria testing in chronic kidney disease?: Good evidence can clarify a potentially confusing message.

Fraser SD, Roderick PJ, Taal MW.

Br J Gen Pract. 2016 Apr;66(645):215-7. doi: 10.3399/bjgp16X684721. No abstract available.

27.

The epidemiology of hospitalised acute kidney injury not requiring dialysis in England from 1998 to 2013: retrospective analysis of hospital episode statistics.

Kolhe NV, Muirhead AW, Wilkes SR, Fluck RJ, Taal MW.

Int J Clin Pract. 2016 Apr;70(4):330-9. doi: 10.1111/ijcp.12774. Epub 2016 Jan 22.

28.

The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study.

Fraser SD, Roderick PJ, May CR, McIntyre N, McIntyre C, Fluck RJ, Shardlow A, Taal MW.

BMC Nephrol. 2015 Dec 1;16:193. doi: 10.1186/s12882-015-0189-z.

29.

Correction: The Association between Polyclonal Combined Serum Free Light Chain Concentration and Mortality in Individuals with Early Chronic Kidney Disease.

Assi LK, McIntyre N, Fraser S, Harris S, Hutchison CA, McIntyre CW, Cockwell P, Taal MW.

PLoS One. 2015 Oct 20;10(10):e0141404. doi: 10.1371/journal.pone.0141404. eCollection 2015. No abstract available.

30.

Chronic kidney disease in older people - diagnosis, aetiology and consequences.

Taal MW.

Curr Opin Nephrol Hypertens. 2015 Nov;24(6):475-9. doi: 10.1097/MNH.0000000000000164. Review.

PMID:
26371527
31.

Long Term Outcomes after Acute Kidney Injury: Lessons from the ARID Study.

Horne KL, Shardlow A, Taal MW, Selby NM.

Nephron. 2015;131(2):102-6. doi: 10.1159/000439066. Epub 2015 Sep 5. Review.

32.

Reduction in sodium intake is independently associated with improved blood pressure control in people with chronic kidney disease in primary care.

Nerbass FB, Pecoits-Filho R, McIntyre NJ, Shardlow A, McIntyre CW, Taal MW.

Br J Nutr. 2015 Sep 28;114(6):936-42. doi: 10.1017/S0007114515002494. Epub 2015 Aug 5.

PMID:
26243465
33.

National trends in acute kidney injury requiring dialysis in England between 1998 and 2013.

Kolhe NV, Muirhead AW, Wilkes SR, Fluck RJ, Taal MW.

Kidney Int. 2015 Nov;88(5):1161-9. doi: 10.1038/ki.2015.234. Epub 2015 Jul 29.

PMID:
26221750
34.

Impact of Compliance with a Care Bundle on Acute Kidney Injury Outcomes: A Prospective Observational Study.

Kolhe NV, Staples D, Reilly T, Merrison D, Mcintyre CW, Fluck RJ, Selby NM, Taal MW.

PLoS One. 2015 Jul 10;10(7):e0132279. doi: 10.1371/journal.pone.0132279. eCollection 2015.

35.

Risk factors: The kidneys find a voice in cardiovascular risk prediction.

Taal MW.

Nat Rev Nephrol. 2015 Sep;11(9):510-2. doi: 10.1038/nrneph.2015.109. Epub 2015 Jul 7. No abstract available.

PMID:
26149837
36.

The Association between Polyclonal Combined Serum Free Light Chain Concentration and Mortality in Individuals with Early Chronic Kidney Disease.

Assi LK, McIntyre N, Fraser S, Harris S, Hutchison CA, McIntyre CW, Cockwell P, Taal MW.

PLoS One. 2015 Jul 1;10(7):e0129980. doi: 10.1371/journal.pone.0129980. eCollection 2015. Erratum in: PLoS One. 2015;10(10):e0141404.

37.

Exploration of chronic kidney disease prevalence estimates using new measures of kidney function in the health survey for England.

Fraser SD, Aitken G, Taal MW, Mindell JS, Moon G, Day J, O'Donoghue D, Roderick PJ.

PLoS One. 2015 Feb 20;10(2):e0118676. doi: 10.1371/journal.pone.0118676. eCollection 2015.

38.

Development of a formula for estimation of sodium intake from spot urine in people with chronic kidney disease.

Nerbass FB, Pecoits-Filho R, McIntyre NJ, McIntyre CW, Taal MW.

Nephron Clin Pract. 2014;128(1-2):61-6. doi: 10.1159/000363297. Epub 2014 Oct 23.

PMID:
25342580
39.

High sodium intake is associated with important risk factors in a large cohort of chronic kidney disease patients.

Nerbass FB, Pecoits-Filho R, McIntyre NJ, McIntyre CW, Taal MW.

Eur J Clin Nutr. 2015 Jul;69(7):786-90. doi: 10.1038/ejcn.2014.215. Epub 2014 Oct 8.

PMID:
25293433
40.

Progress in risk prediction for people with chronic kidney disease.

Taal MW.

Curr Opin Nephrol Hypertens. 2014 Nov;23(6):519-24. doi: 10.1097/MNH.0000000000000072. Review.

PMID:
25226275
41.

Skin autofluorescence and all-cause mortality in stage 3 CKD.

Fraser SD, Roderick PJ, McIntyre NJ, Harris S, McIntyre CW, Fluck RJ, Taal MW.

Clin J Am Soc Nephrol. 2014 Aug 7;9(8):1361-8. doi: 10.2215/CJN.09510913. Epub 2014 May 29.

42.

Assessment of proteinuria in patients with chronic kidney disease stage 3: albuminuria and non-albumin proteinuria.

Fraser SD, Roderick PJ, McIntyre NJ, Harris S, McIntyre C, Fluck R, Taal MW.

PLoS One. 2014 May 27;9(5):e98261. doi: 10.1371/journal.pone.0098261. eCollection 2014.

43.

Demographic associations of high estimated sodium intake and frequency of consumption of high-sodium foods in people with chronic kidney disease stage 3 in England.

Nerbass FB, Pecoits-Filho R, McIntyre NJ, McIntyre CW, Willingham FC, Taal MW.

J Ren Nutr. 2014 Jul;24(4):236-42. doi: 10.1053/j.jrn.2014.03.003. Epub 2014 Apr 29.

PMID:
24788310
44.

The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease.

Taal MW, Thurston V, McIntyre NJ, Fluck RJ, McIntyre CW.

Kidney Int. 2014 Aug;86(2):407-13. doi: 10.1038/ki.2013.537. Epub 2014 Jan 15.

45.

The eGFR-C study: accuracy of glomerular filtration rate (GFR) estimation using creatinine and cystatin C and albuminuria for monitoring disease progression in patients with stage 3 chronic kidney disease--prospective longitudinal study in a multiethnic population.

Lamb EJ, Brettell EA, Cockwell P, Dalton N, Deeks JJ, Harris K, Higgins T, Kalra PA, Khunti K, Loud F, Ottridge RS, Sharpe CC, Sitch AJ, Stevens PE, Sutton AJ, Taal MW; eGFR-C study group.

BMC Nephrol. 2014 Jan 14;15:13. doi: 10.1186/1471-2369-15-13.

46.

Arterial stiffness in chronic kidney disease: an update.

Taal MW.

Curr Opin Nephrol Hypertens. 2014 Mar;23(2):169-73. doi: 10.1097/01.mnh.0000441153.40072.e0. Review.

PMID:
24389732
47.

Tissue advanced glycation end product deposition after kidney transplantation.

Crowley LE, Johnson CP, McIntyre N, Fluck RJ, McIntyre CW, Taal MW, Leung JC.

Nephron Clin Pract. 2013;124(1-2):54-9. doi: 10.1159/000355692. Epub 2013 Oct 15.

PMID:
24135496
48.

Chronic kidney disease in general populations and primary care: diagnostic and therapeutic considerations.

Taal MW.

Curr Opin Nephrol Hypertens. 2013 Nov;22(6):593-8. doi: 10.1097/MNH.0b013e328365adf6. Review.

PMID:
24104481
49.

Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary care.

Fraser SD, Roderick PJ, McIntyre NJ, Harris S, McIntyre CW, Fluck RJ, Taal MW.

BMC Fam Pract. 2013 Jun 24;14:88. doi: 10.1186/1471-2296-14-88.

50.

Natural history of skeletal muscle mass changes in chronic kidney disease stage 4 and 5 patients: an observational study.

John SG, Sigrist MK, Taal MW, McIntyre CW.

PLoS One. 2013 May 31;8(5):e65372. doi: 10.1371/journal.pone.0065372. Print 2013.

Supplemental Content

Support Center